Legis Daily

To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative standard for substantial equivalence determinations for devices, and for other purposes.

USA115th CongressHR-2474| House 
| Updated: 5/19/2017
Mimi Walters

Mimi Walters

Republican Representative

California

Cosponsors (1)
Ami Bera (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medical Product Review Harmonization Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to establish an alternative standard for demonstrating a device's substantial equivalence to a medical device that has already been approved by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 16, 2017
Introduced in House
May 16, 2017
Referred to the House Committee on Energy and Commerce.
May 19, 2017
Referred to the Subcommittee on Health.
  • May 16, 2017
    Introduced in House


  • May 16, 2017
    Referred to the House Committee on Energy and Commerce.


  • May 19, 2017
    Referred to the Subcommittee on Health.

Health

Drug safety, medical device, and laboratory regulationHealth technology, devices, suppliesPublic participation and lobbying

To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative standard for substantial equivalence determinations for devices, and for other purposes.

USA115th CongressHR-2474| House 
| Updated: 5/19/2017
Medical Product Review Harmonization Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to establish an alternative standard for demonstrating a device's substantial equivalence to a medical device that has already been approved by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 16, 2017
Introduced in House
May 16, 2017
Referred to the House Committee on Energy and Commerce.
May 19, 2017
Referred to the Subcommittee on Health.
  • May 16, 2017
    Introduced in House


  • May 16, 2017
    Referred to the House Committee on Energy and Commerce.


  • May 19, 2017
    Referred to the Subcommittee on Health.
Mimi Walters

Mimi Walters

Republican Representative

California

Cosponsors (1)
Ami Bera (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug safety, medical device, and laboratory regulationHealth technology, devices, suppliesPublic participation and lobbying